Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PTE PolarityTE, Inc. daily Stock Chart
PTE [NASD]
PolarityTE, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-5.69 Insider Own35.50% Shs Outstand22.18M Perf Week-20.57%
Market Cap289.45M Forward P/E- EPS next Y-3.28 Insider Trans- Shs Float9.91M Perf Month-15.20%
Income-74.20M PEG- EPS next Q-1.06 Inst Own56.50% Short Float71.49% Perf Quarter-19.29%
Sales1.60M P/S180.91 EPS this Y81.70% Inst Trans4.13% Short Ratio24.56 Perf Half Y-29.50%
Book/sh3.84 P/B3.40 EPS next Y20.20% ROA-120.80% Target Price43.75 Perf Year-24.17%
Cash/sh3.20 P/C4.08 EPS next 5Y15.00% ROE-288.00% 52W Range11.54 - 41.22 Perf YTD-3.26%
Dividend- P/FCF- EPS past 5Y17.60% ROI-83.40% 52W High-68.34% Beta1.26
Dividend %- Quick Ratio13.70 Sales past 5Y-49.40% Gross Margin35.90% 52W Low13.08% ATR1.44
Employees123 Current Ratio13.80 Sales Q/Q- Oper. Margin- RSI (14)42.21 Volatility12.86% 9.64%
OptionableYes Debt/Eq0.01 EPS Q/Q96.00% Profit Margin- Rel Volume3.55 Prev Close15.47
ShortableYes LT Debt/Eq0.01 EarningsMar 18 Payout- Avg Volume288.52K Price13.05
Recom1.80 SMA20-6.04% SMA50-15.03% SMA200-31.47% Volume1,023,857 Change-15.64%
Jan-28-19Initiated Northland Capital Outperform $50
Jan-28-19Initiated National Securities Sell $5
Dec-20-18Initiated Piper Jaffray Overweight
Mar-18-19 07:56PM  Bragar Eagel & Squire, P.C. is Investigating PolarityTE, Inc. (PTE) on Behalf of Stockholders and Encourages PTE Investors to Contact the Firm GlobeNewswire -15.64%
05:40PM  PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation Of PolarityTE, Inc. - PTE PR Newswire
04:20PM  Why PolarityTE Stock Tanked Today Motley Fool
02:16PM  Biotech's shares tumble after it says SEC is looking into possible manipulation CNBC
07:00AM  PolarityTE Reports Results and Corporate Update for Two-Month Transition Period Ended December 31, 2018 PR Newswire
Mar-14-19 10:20AM  Read This Before Buying PolarityTE, Inc. (NASDAQ:PTE) Shares Simply Wall St.
Mar-13-19 08:45AM  PolarityTE to Attend Medlab Asia Pacific and Asia Health 2019 Conferences PR Newswire
Mar-11-19 11:39AM  Why PolarityTE Stock Is Shooting Higher Today Motley Fool +22.25%
10:30AM  Will Polarity (PTE) Report Negative Q1 Earnings? What You Should Know Zacks
Mar-06-19 04:01PM  PolarityTE to Present at the 39th Annual Cowen Healthcare Conference and at the 13th Annual Canaccord Genuity Musculoskeletal Conference PR Newswire
Mar-05-19 08:00AM  Congressional Health Care Innovation Showcase to Feature PolarityTE PR Newswire
Feb-27-19 08:00AM  PolarityTE Presents Platform Technology at Department of Defense Pacific Operational Science and Technology (POST) Conference PR Newswire
Feb-25-19 10:10AM  Zacks.com featured expert Kevin Matras highlights: Shenandoah Telecommunications, Honda Motor, PolarityTE, Ubiquiti Networks and Titan Machinery Zacks
Feb-22-19 09:06AM  5 Stocks to Buy as New Analysts Initiate Coverage Zacks
Feb-06-19 07:12AM  PolarityTE, Inc. (NASDAQ:PTE): The Best Of Both Worlds Simply Wall St.
Feb-01-19 11:30AM  LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE
08:00AM  Boswick Burn and Wound Symposium: New Data to be Presented on Preclinical and Clinical Use of SkinTE PR Newswire
Jan-29-19 04:15PM  PolarityTE Names Board Member David Seaburg as President of Corporate Development PR Newswire
Jan-23-19 08:50AM  Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks
08:00AM  World Stem Cell Summit: PolarityTE to Present Abstract on Regenerative Platform Technology PR Newswire
Jan-14-19 07:00AM  PolarityTE Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
Jan-07-19 08:00AM  PolarityTE Expands Contract Services Business with Addition of Jon Burrows PR Newswire -6.13%
Jan-03-19 08:00AM  PolarityTE to Report Fiscal Fourth Quarter Financial Results on January 14, 2019 PR Newswire
Dec-28-18 08:00AM  PolarityTE Registers OsteoTE with U.S. Food and Drug Administration PR Newswire
Dec-27-18 08:00AM  PolarityTE to Participate in Corporate Access Event in San Francisco, January 7-9, 2019 PR Newswire
Dec-24-18 10:21AM  Investors Are Undervaluing PolarityTE, Inc. (NASDAQ:PTE) By 32.74% Simply Wall St.
Dec-19-18 08:00AM  PolarityTE and University Hospitals Cleveland Medical Center Announce System-Wide Approval of SkinTE PR Newswire +8.85%
Dec-11-18 08:00AM  PolarityTE Announces Former FDA Official and Johnson & Johnson Executive Minnie Baylor-Henry Joins Board of Directors PR Newswire +17.64%
Dec-04-18 08:00AM  PolarityTE to Present SkinTE Clinical Outcomes at Innovations in Wound Healing Conference PR Newswire -7.19%
Nov-29-18 08:00AM  PolarityTE Announces Recognition of SkinTE as Finalist for Fierce Innovation Awards Biotech Innovation PR Newswire
Nov-27-18 07:00AM  PolarityTE Announces Matt Kemp as Chief Commercial Officer PR Newswire
Nov-21-18 08:00AM  PolarityTE Receives Unique HCPCS Q-Code for SkinTE for Product Reimbursement from CMS PR Newswire +8.31%
Nov-15-18 08:00AM  PolarityTE to Participate in Piper Jaffray 30th Annual Healthcare Conference PR Newswire
Nov-14-18 08:00AM  PolarityTE to Participate in Evercore ISI Healthcare Conference PR Newswire
Nov-07-18 08:00AM  PolarityTE to Sponsor Epidermolysis Bullosa Research Partnership Event "ACTion for Jackson" in New York PR Newswire
Nov-02-18 08:00AM  PolarityTE® to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum PR Newswire
Nov-01-18 08:00AM  PolarityTE® Announces Presentation of SkinTE Clinical Outcomes at Symposium on Advanced Wound Care PR Newswire
Oct-29-18 03:02PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against PolarityTE, Inc. (PTE) and Encourages PTE Investors to Contact the Firm GlobeNewswire
08:00AM  PolarityTE® Supports Development of Utah Biotech and Life Sciences Community PR Newswire
Oct-18-18 12:29PM  PolarityTE Issues Statement on Misleading Internet Post PR Newswire -17.05%
08:00AM  PolarityTE® Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access PR Newswire
Oct-15-18 07:24PM  Robbins Arroyo LLP: PolarityTE, Inc. (PTE) Misled Shareholders According to a Class Action Business Wire +8.76%
Oct-12-18 08:02AM  Moving Average Crossover Alert: PolarityTE (PTE) Zacks -9.81%
Oct-09-18 10:52AM  Cool Mara Riot, Part Two: Securities-Fraud Case Against South Florida Group Reverberates Through Additional Companies Benzinga
09:15AM  PolarityTE® Announces Reporting of Apparent Intentional Market Manipulation by Third Parties to Regulatory Authorities PR Newswire
Oct-05-18 08:00AM  PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE PR Newswire
Sep-26-18 08:00AM  PolarityTE Announces the Expansion of the Sales Team in the Regional Market Release of SkinTE PR Newswire -10.27%
Sep-24-18 08:00AM  PolarityTE Announces Presentations of SkinTE Clinical Results at Upcoming Plastic Surgery Conferences PR Newswire
Sep-20-18 08:00AM  PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference PR Newswire +13.37%
Mar-23-18 05:08AM  Should Parcel Technik SA.s (WSE:PTE) Recent Earnings Decline Worry You? Simply Wall St.
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
open in yahoo | open in reuters | open in google